Article
The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
Alzheimer's research & therapy - 30 Jun 2016
Yassine Hussein N, Rawat Varun, Mack Wendy J, Quinn Joseph F, Yurko-Mauro Karin, Bailey-Hall Eileen, Aisen Paul S, Chui Helena C, Schneider Lon S
Abstract excerpt
BACKGROUND: Apolipoprotein E (APOE) ɛ4 and low cerebrospinal fluid (CSF) amyloid-β42 (Aβ42) levels are predictors for developing Alzheimer's disease (AD). The results of several studies indicate an interaction between docosahexaenoic acid (DHA) consumption and cognitive outcomes by APOE genotype. Our objective in the present study was to examine whether APOE ɛ4 genotype and low CSF Aβ42 levels were associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
